Golden Star Resources Ltd (GSS) 0.27 $GSS Gold Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Golden Star Resources Ltd (GSS) 0.27 $GSS

Gold Stocks Technical Coverage -- Goldcorp, McEwen Mining, Golden Star Resources, Cia de Minas Buenaventura, and Royal Gold
PR Newswire - Fri Mar 13, 7:55AM CDT
Editor Note: For more information about this release, please scroll to bottom.
GSS: 0.27 (+0.01), BVN: 10.90 (-0.09), RGLD: 67.51 (+1.25), MUX: 1.06 (unch), GG: 19.17 (+0.56)

Freeport's Production Test at Highlander Well a Success - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 1:27PM CST
Freeport-McMoRan Inc. (FCX) reported the results of additional production testing on Freeport-McMoRan Oil & Gas' (FM O&G) Highlander discovery well.
GSS: 0.27 (+0.01), NCQ: 0.65 (-0.02), LSG: 0.83 (+0.02), FCX: 18.41 (+1.15)

Newmont Beats on Q4 Earnings and Revenue Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 8:28AM CST
Newmont's (NEM) fourth-quarter earnings and revenues topped expectations.
GSS: 0.27 (+0.01), GFI: 4.36 (+0.15), NEM: 22.95 (+0.13), GSV: 0.45 (unch)

Harmony Gold's (HMY) Strategic Actions Show Potential - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 2:49PM CST
We have issued an updated research report on South African gold miner Harmony Gold (HMY).
GSS: 0.27 (+0.01), HMY: 1.93 (+0.10), LSG: 0.83 (+0.02), NEM: 22.95 (+0.13)

Golden Star Resources' (GSS) CEO Samuel Coetzer Discusses on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 19, 12:42PM CST

GSS: 0.27 (+0.01)

Barrick (ABX) Beats Q4 Earnings, Plans to Cut Debt - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 7:58AM CST
Barrick Gold's (ABX) adjusted earnings (excluding one-time items) for the fourth quarter of 2014 plummeted to 15 cents per share from 37 cents per share in the year-ago quarter but beat the Zacks Consensus Estimate of 12 cents.
GSS: 0.27 (+0.01), ABX: 11.10 (+0.21), LSG: 0.83 (+0.02), NEM: 22.95 (+0.13)

Golden Star Resources EPS of -$0.19
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 6:10AM CST

GSS: 0.27 (+0.01)

Golden Star Fourth Quarter and Full Year 2014 Financial Results: Fourth consecutive quarter of lower costs
PR Newswire - Thu Feb 19, 6:00AM CST
Golden Star today reports its financial results for the quarter and full year ended December 31, 2014 ("the fourth quarter" and "the year" respectively). All references to currency are to US dollars.
GSS: 0.27 (+0.01), GSC.TO: 0.34 (+0.01)

Golden Star Year End 2014 Results Conference Call
CNW Group - Thu Feb 12, 8:30AM CST
Golden Star will be releasing its year end 2014 financial results before market open on February 19, 2015. The Company will host a conference call and webcast to discuss these results on the same day at 10:00 am EST.
GSS: 0.27 (+0.01), GSC.TO: 0.34 (+0.01)

Kinross Gold (KGC) Posts Loss in Q4, Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:12AM CST
Kinross Gold Corporation (KGC) reported a net loss of $1,473.5 million (or $1.29 per share) in the fourth quarter of 2014, significantly wider than a net loss of $740 million (or 65 cents a share) recorded in the year-ago quarter.
GSS: 0.27 (+0.01), LSG: 0.83 (+0.02), KGC: 2.42 (+0.06), GSV: 0.45 (unch)

Harmony Gold (HMY) Posts Loss in Q2 on Lower Gold Price - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:00AM CST
Harmony Gold (HMY) posts wider net loss in the second quarter of fiscal 2015.
GSS: 0.27 (+0.01), HMY: 1.93 (+0.10), LSG: 0.83 (+0.02), GSV: 0.45 (unch)

Cliffs Natural (CLF) to Restructure Bloom Lake Mine - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 5:00PM CST
Cliffs Natural Resources Inc. (CLF) said that Bloom Lake General Partner Limited and certain of its affiliates have started restructuring proceedings in Montreal, Quebec, under the Companies' Creditors Arrangement Act (Canada) ("CCAA" .
GSS: 0.27 (+0.01), LSG: 0.83 (+0.02), CLF: 4.30 (-0.01), PVG: 5.62 (+0.18)

Gold Equities Coverage -- Agnico Eagle Mines, B2Gold, NOVAGOLD Resources, Golden Star Resources, and Banro
PR Newswire - Fri Jan 23, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Agnico Eagle Mines Ltd (NYSE: AEM), B2Gold Corporation (NYSE MKT: BTG), NOVAGOLD Resources Inc. (NYSE MKT: NG), Golden Star Resources Ltd (NYSE MKT: GSS), and Banro Corporation (NYSE MKT: BAA). Free research report on Agnico Eagle Mines can be accessed at http://get.Investor-Edge.com/pdf/?c=Agnico%20...&s=AEM. On Thursday, January 22, 2015, the NASDAQ Composite ended at 4,750.40, up 1.78%, the Dow Jones Industrial Average advanced 1.48%, to finish the day at 17,813.98, and the S&P 500 closed at 2,063.15, up 1.53%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Materials Sector Index ended the day at 307.79, up 1.30%, with the index also advancing 2.41% in the previous three trading sessions. Register for your complimentary reports at the links given below.
GSS: 0.27 (+0.01), NG: 3.05 (+0.03), BTG: 1.63 (+0.11), AEM: 29.72 (+1.16), BAA: 0.22 (+0.02)

Royal Gold Gives Updates on Mount Milligan, Penasquito - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 3:50PM CST
Royal Gold Inc. (RGLD) said that the operators of the Mount Milligan and Penasquito properties have released preliminary operating results for 2014 along with production forecasts for 2015.
GSS: 0.27 (+0.01), RGLD: 67.51 (+1.25), PVG: 5.62 (+0.18), GG: 19.17 (+0.56)

Newmont Divests Mining, Surface Rights to Pershing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 5:33PM CST
Newmont (NEM) announces divestiture of exclusive mining and surface use rights to Pershing Gold Corporation.
GSS: 0.27 (+0.01), RBY: 0.93 (+0.02), NEM: 22.95 (+0.13), PVG: 5.62 (+0.18)

Kinross Gold Extends Offer for $500M in 5.95% Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 5:11PM CST
Kinross Gold Corporation (KGC) announced that it has extended its offer to exchange up to $500 million principal amount of its 5.95% senior notes, due 2024, to Jan 23, 2015.
GSS: 0.27 (+0.01), RBY: 0.93 (+0.02), KGC: 2.42 (+0.06), PVG: 5.62 (+0.18)

Golden Star Resources (GSS) Looks Good: Stock Up 16.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 7:51AM CST
Golden Star Resources, Ltd. (GSS) was a big mover last session, as its shares rose over 16% on the day.
GSS: 0.27 (+0.01), SAND: 3.30 (+0.17)

Hot Stock: Golden Star Resources, Shares Gain 21.9% (GSS)
Comtex SmarTrend(R) - Tue Jan 20, 10:37AM CST
Golden Star Resources (AMEX:GSS) is one of today's best performing penny stocks, up 21.9% to $0.35 on 1.0x average daily volume. Golden Star Resources has traded 4.1 million shares thus far today, vs. average volume of 4.0 million shares per day. The stock has outperformed the Dow (21.9% to the Dow's -0.6%) and outperformed the S&P 500 (21.9% to the S&P's -0.3%) during today's trading.
GSS: 0.27 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles